Christiana Care Health Services
Newark, Delaware, 19718, United States
NCT Number: NCT00388830
The purpose of this study is to determine whether fasting for 8 hours prior to ultrasonography for cholelithiasis (gallbladder pain) is needed.
Looking for future studies?
Notify Me18 year–75 year
All sexes
Interventional
Not applicable
Newark, Delaware, 19718, United States
Ultrasonography of the gallbladder is currently the diagnostic modality of choice in determining cholelithiasis and cholecystitis. Historically this test has been performed in the Radiology suites where the patient was expected to fast for times of six to ten hours. Patients presenting to emergency departments (ED) have also been required to wait to have their study performed in order to have better visualization of the gallbladder. However, few studies have examined whether a fasting time matters in determining gallbladder pathology. Furthermore, with the emphasis on through-times in the ED, most EDs cannot afford holding their patients in the ED to wait for a test. Finally, with the advent of emergency bedside ultrasonography and the greater level of comfort emergency physicians (EP) have in diagnosing gallbladder pathology, it is possible to now determine an answer within minutes. We will test to see if EPs trained in the use of emergency bedside ultrasound can effectively and efficiently determine gallbladder pathology and if fasting has an impact on their ability to perform a quality ultrasound.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Christiana Care Health Services
Other
"Emergency Bedside Ultrasonography of the Gallbladder: Does Fasting Matter?"
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07696078
Biliary Tract Diseases, Cholecystitis
View Trial DetailsNCT05900037
Biliary Tract Diseases, Blood Loss, Surgical
Los Angeles, California, United States
View Trial DetailsNCT07363668
Biliary Tract Diseases, Cholecystitis
Erzurum, Turkey (Türkiye)
View Trial DetailsNCT07021300
Acute Cholecystitis, Biliary Tract Diseases
Peshawar, Khyber Pakhtunkhwa, Pakistan
View Trial Details